Fingerprint
Dive into the research topics of 'The efficacy and safety of panitumumab administered concomitantly with FOLFIRI or irinotecan in second-line therapy for metastatic colorectal cancer: The secondary analysis from STEPP (skin toxicity evaluation protocol with panitumumab) by KRAS status'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically